Table 4.
Results of Salvage Radiation Therapy for Loco-Regional Recurrent NSCLC
NSCLC, non-small cell lung cancer.
*Includes only those treated with curative aim.
†5-years overall survival rate.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.